|1.||Miller, Laurence J: 6 articles (04/2008 - 02/2002)|
|2.||Gaudio, Eugenio: 5 articles (07/2013 - 04/2010)|
|3.||Francis, Heather: 5 articles (07/2013 - 04/2010)|
|4.||Carpino, Guido: 5 articles (07/2013 - 04/2010)|
|5.||Onori, Paolo: 5 articles (07/2013 - 04/2010)|
|6.||Franchitto, Antonio: 5 articles (07/2013 - 04/2010)|
|7.||Mancinelli, Romina: 4 articles (07/2013 - 04/2010)|
|8.||Venter, Julie: 4 articles (07/2013 - 04/2010)|
|9.||Alpini, Gianfranco: 4 articles (07/2013 - 04/2010)|
|10.||Glaser, Shannon: 4 articles (07/2013 - 04/2010)|
10/01/2005 - "This study is the first to describe the precise secretin receptor distribution in human non-neoplastic pancreas and various pancreatic tumors. "
08/01/2012 - "Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway."
04/01/2008 - "Secretin receptor mis-splicing specifically occurs in tumor and non-tumor lung pathology."
04/01/2008 - "In the autoradiographically positive peritumoral lung, RT-PCR showed transcripts for the wild-type secretin receptor and for a secretin receptor spliceoform different from those occurring in lung and gut tumors. "
04/01/2008 - "In tumors found to be secretin receptor positive by autoradiography, RT-PCR revealed transcripts for the wild-type secretin receptor and for novel secretin receptor splice variants. "
04/01/2002 - "1. The present study investigated the role of second messenger-dependent protein kinase A (PKA) and C (PKC) in the regulation of endogenous secretin receptor responsiveness in NG108-15 mouse neuroblastomaxrat glioma hybrid cells. "
10/05/1990 - "Secretin receptors in membranes from the neuroblastoma-glioma hybrid cell line NG108-15 were investigated by 125I-secretin binding and adenylate cyclase activation. "
02/01/2003 - "1. To determine the role of G protein-coupled receptor kinases (GRKs) in the regulation of endogenous secretin receptor responsiveness, we have transiently overexpressed both wild-type (WT) and dominant negative mutant (DNM) GRKs in NG108-15 mouse neuroblastoma x rat glioma hybrid cells and investigated the effects of this on agonist-stimulated adenylyl cyclase activity. "
11/01/2007 - "Secretin-receptor and secretin-receptor-variant expressions occur in all gastrinomas. "
02/01/2002 - "We confirmed the molecular nature of the secretin receptor in the gastrinomas with a positive provocative test result and identified a novel mechanism for a false-negative result. "
02/01/1997 - "Secretin receptors were expressed in four primary gastrinomas and one primary VIPoma from pancreas. "
02/01/2002 - "Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma."
11/01/2007 - "Secretin-receptor and variant mRNA expression was determined in gastrinomas using real-time PCR from 54 Zollinger-Ellison syndrome patients. "
09/15/2002 - "Secretin receptors that are key for regulation of healthy pancreatic ductal epithelial cells have been reported to be functionally absent on ductal pancreatic adenocarcinomas. "
09/15/2002 - "Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma."
04/15/1997 - "Recent data from our laboratory suggest expression of a low affinity secretin receptor in seven cell lines derived from human ductal pancreatic adenocarcinomas. "
10/01/1996 - "The specific CCK-A and secretin receptors expressed in normal pancreata were markedly reduced in pancreatic preneoplastic lesions and absent in adenocarcinomas. "
10/01/2005 - "Secretin receptors were highly expressed in non-neoplastic ducts and lobuli and also in lower amounts in ductal neoplasias, including ductal adenocarcinoma, intraductal papillary mucinous tumors, and pancreatic intraepithelial neoplasia. "
|1.||Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
|3.||Adenylate Cyclase (Adenylyl Cyclase)
|4.||Messenger RNA (mRNA)
|5.||GTP-Binding Proteins (G-Protein)
|6.||Complementary DNA (cDNA)
|7.||Glucagon-Like Peptide 1 (GLP 1)
|8.||Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)